Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hannah B Ibanga"'
Autor:
Roger H Brookes, Philip C Hill, Patrick K Owiafe, Hannah B Ibanga, David J Jeffries, Simon A Donkor, Helen A Fletcher, Abdulrahman S Hammond, Christian Lienhardt, Richard A Adegbola, Helen McShane, Adrian V S Hill
Publikováno v:
PLoS ONE, Vol 3, Iss 8, p e2921 (2008)
Vaccination with a recombinant modified vaccinia Ankara expressing antigen 85A from Mycobacterium tuberculosis, MVA85A, induces high levels of cellular immune responses in UK volunteers. We assessed the safety and immunogenicity of this new vaccine i
Externí odkaz:
https://doaj.org/article/697f4bd9c458402b84d34e49123f0eb1
Autor:
Roger H. Brookes, Philip C. Hill, Patrick K. Owiafe, Hannah B. Ibanga, David J. Jeffries, Simon A. Donkor, Helen A. Fletcher, Abdulrahman S. Hammond, Christian Lienhardt, Richard A. Adegbola, Helen McShane, Adrian V. S. Hill
Publikováno v:
PLoS ONE, Vol 6, Iss 2 (2011)
Externí odkaz:
https://doaj.org/article/94b1803b00f7497080853b9489ec2e71
Autor:
Roger H. Brookes, Hannah B. Ibanga, Helen McShane, Martin O. C. Ota, Philip C. Hill, Jayne S. Sutherl, Patrick K. Owiafe
MVA85A is a candidate boost vaccine for TB. A previously reported study showed no differences in response to MVA85A in 10 BCG vaccinated (BCG+) and 11 BCG naive (BCG-) adult Gambians. Here we evaluated the effect of pre-existing plasma cytokines in b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4236f182abc1de303d5a2d45b87cab1
https://doi.org/10.4172/2157-7560.1000158
https://doi.org/10.4172/2157-7560.1000158
Autor:
Martin O. C. Ota, Patrick K. Owiafe, Richard A. Adegbola, Helen McShane, Timothy Awine, Simon Donkor, Philip C. Hill, Hannah B. Ibanga, Roger H. Brookes
Understanding the immunogenicity of BCG in a population where it has failed will facilitate the design of new TB vaccines. We assessed the immunogenicity of M. bovis BCG over 12 months by ELISPOT assay. Forty-one adolescents and young Gambian male ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f07127d68b77dda6803ff43a5f5e65e
https://ora.ox.ac.uk/objects/uuid:903ac5f4-250b-4c67-bfac-6f80407eff4b
https://ora.ox.ac.uk/objects/uuid:903ac5f4-250b-4c67-bfac-6f80407eff4b
Haematological values from a Gambian cohort - possible reference range for a West African population
Autor:
Simon Donkor, David Jeffries, Richard A. Adegbola, Dolly Jackson-Sillah, Hannah B. Ibanga, Ifedayo M. O. Adetifa, G. Bah, Tumani Corrah, Philip C. Hill
Publikováno v:
International Journal of Laboratory Hematology. 31:615-622
Summary The objective of this study was to establish haematological reference ranges for the West African subregion using a Gambian cohort. We analysed full blood counts from 1279 subjects aged ≥1 year. Anthropometric and body composition measureme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fa3bc64bd7426a7700aec49a81dbb22
https://doi.org/10.1111/j.1751-553x.2008.01087.x
https://doi.org/10.1111/j.1751-553x.2008.01087.x
Autor:
Philip C. Hill, Moses D. Lugos, Simon Donkor, Nicholas J. Battersby, Abdulrahman S. Hammond, Hannah B. Ibanga, Martin O. C. Ota, Richard A. Adegbola, David Jeffries, Martin Antonio, Robert Walton, Roger H. Brookes, Ifedayo M. O. Adetifa, Peter Aka, Patrick K. Owiafe
Publikováno v:
American journal of respiratory and critical care medicine. 187(4)
Biomarkers that can be used to evaluate new interventions against latent tuberculosis infection (LTBI) and predict reactivation TB disease are urgently required.To evaluate ESAT-6 and CFP-10 (EC) IFN-γ ELISPOT as a biomarker for treatment efficacy i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faf1f33a89ea603450a30cf23c951f02
https://pubmed.ncbi.nlm.nih.gov/23220919
https://pubmed.ncbi.nlm.nih.gov/23220919
Autor:
Helen A. Fletcher, Adrian V. S. Hill, David Jeffries, Abdulrahman S. Hammond, Richard A. Adegbola, Christian Lienhardt, Roger H. Brookes, Helen McShane, Philip C. Hill, Hannah B. Ibanga, Simon Donkor, Patrick K. Owiafe
Publikováno v:
PLoS ONE, Vol 6, Iss 2 (2011)
PLoS ONE
PLoS ONE
The following information was missing from the Funding section: "The study was supported by funding from the NIHR Oxford Biomedical Research Centre programme."
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3d0a5583c010951d5ce8fb0819b3bbc
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072427/?tool=EBI
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072427/?tool=EBI
Autor:
Christian Lienhardt, Adrian V. S. Hill, Simon Donkor, Hannah B. Ibanga, Philip C. Hill, David Jeffries, Roger H. Brookes, Abdulrahman S. Hammond, Patrick K. Owiafe, Richard A. Adegbola, Helen A. Fletcher, Helen McShane
Publikováno v:
PLoS ONE, Vol 3, Iss 8, p e2921 (2008)
PLoS ONE
PLoS ONE
BACKGROUND Vaccination with a recombinant modified vaccinia Ankara expressing antigen 85A from Mycobacterium tuberculosis, MVA85A, induces high levels of cellular immune responses in UK volunteers. We assessed the safety and immunogenicity of this ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b9f4e1c1240eacbce9b712af8771459
http://europepmc.org/articles/PMC2488375?pdf=render
http://europepmc.org/articles/PMC2488375?pdf=render
Autor:
Helen McShane, Adrian V. S. Hill, Patrick K. Owiafe, Helen A. Fletcher, Hannah B. Ibanga, Christian Lienhardt, Philip C. Hill, Roger H. Brookes, Richard A. Adegbola
Tuberculosis remains a substantial global health problem despite effective drug treatments. The efficacy of BCG, the only available vaccine, is variable, especially in tuberculosis-endemic regions. Recent advances in the development of new vaccines a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0228681069c8356d10807655cb2ae937
http://www.documentation.ird.fr/hor/fdi:010035752
http://www.documentation.ird.fr/hor/fdi:010035752